Search | VHL Search Portal

1.

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.

Hicks, Stuart W; Tarantelli, Chiara; Wilhem, Alan; Gaudio, Eugenio; Li, Min; Arribas, Alberto J; Spriano, Filippo; Bordone, Roberta; Cascione, Luciano; Lai, Katharine C; Qiu, Qifeng; Taborelli, Monica; Rossi, Davide; Stussi, Georg; Zucca, Emanuele; Stathis, Anastasios; Sloss, Callum M; Bertoni, Francesco.

Haematologica ; 104(8): 1633-1639, 2019 08.

Article in English | MEDLINE | ID: mdl-30733273

2.

Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptor.

Zuckerman, David M; Hicks, Stuart W; Charron, Guillaume; Hang, Howard C; Machamer, Carolyn E.

J Biol Chem ; 286(21): 19014-23, 2011 May 27.

Article in English | MEDLINE | ID: mdl-21464135

3.

A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases.

Quezada, Cindy M; Hicks, Stuart W; Galán, Jorge E; Stebbins, C Erec.

Proc Natl Acad Sci U S A ; 106(12): 4864-9, 2009 Mar 24.

Article in English | MEDLINE | ID: mdl-19273841

4.

Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.

Scribner, Juniper A; Hicks, Stuart W; Sinkevicius, Kerstin W; Yoder, Nicholas C; Diedrich, Gundo; Brown, Jennifer G; Lucas, Jacquelynn; Fuller, Megan E; Son, Thomas; Dastur, Anahita; Hooley, Jeff; Espelin, Christopher; Themeles, Marian; Chen, Francine Z; Li, Ying; Chiechi, Michael; Lee, Jenny; Barat, Bhaswati; Widjaja, Lusiana; Gorlatov, Sergey; Tamura, James; Ciccarone, Valentina; Ab, Olga; McEachem, Kerry A; Koenig, Scott; Westin, Eric H; Moore, Paul A; Chittenden, Thomas; Gregory, Richard J; Bonvini, Ezio; Loo, Deryk.

Mol Cancer Ther ; 21(7): 1047-1059, 2022 07 05.

Article in English | MEDLINE | ID: mdl-35511740

5.

Death from within: apoptosis and the secretory pathway.

Maag, Rebecca S; Hicks, Stuart W; Machamer, Carolyn E.

Curr Opin Cell Biol ; 15(4): 456-61, 2003 Aug.

Article in English | MEDLINE | ID: mdl-12892786

6.

Golgin-160 is required for the Golgi membrane sorting of the insulin-responsive glucose transporter GLUT4 in adipocytes.

Williams, Dumaine; Hicks, Stuart W; Machamer, Carolyn E; Pessin, Jeffrey E.

Mol Biol Cell ; 17(12): 5346-55, 2006 Dec.

Article in English | MEDLINE | ID: mdl-17050738

7.

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.

Hicks, Stuart W; Lai, Katharine C; Gavrilescu, L Cristina; Yi, Yong; Sikka, Surina; Shah, Prerak; Kelly, Meghan E; Lee, Jenny; Lanieri, Leanne; Ponte, Jose F; Sloss, Callum M; Romanelli, Angela.

Neoplasia ; 19(9): 661-671, 2017 Sep.

Article in English | MEDLINE | ID: mdl-28753442

8.

Golgi structure in stress sensing and apoptosis.

Hicks, Stuart W; Machamer, Carolyn E.

Biochim Biophys Acta ; 1744(3): 406-14, 2005 Jul 10.

Article in English | MEDLINE | ID: mdl-15979510

9.

Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.

Catcott, Kalli C; McShea, Molly A; Bialucha, Carl Uli; Miller, Kathy L; Hicks, Stuart W; Saxena, Parmita; Gesner, Thomas G; Woldegiorgis, Mikias; Lewis, Megan E; Bai, Chen; Fleming, Michael S; Ettenberg, Seth A; Erickson, Hans K; Yoder, Nicholas C.

MAbs ; 8(3): 513-23, 2016.

Article in English | MEDLINE | ID: mdl-26752675

10.

Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.

Wilmes, Gwendolyn M; Carey, Kimberly L; Hicks, Stuart W; Russell, Hugh H; Stevenson, Jesse A; Kocjan, Paulina; Lutz, Stephen R; Quesenberry, Rachel S; Shulga-Morskoy, Sergey V; Lewis, Megan E; Clark, Ethan; Medik, Violetta; Cooper, Anthony B; Reczek, Elizabeth E.

MAbs ; 6(4): 957-67, 2014.

Article in English | MEDLINE | ID: mdl-24758837

11.

Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Hicks, Stuart W; Galán, Jorge E.

Nat Rev Microbiol ; 11(5): 316-26, 2013 May.

Article in English | MEDLINE | ID: mdl-23588250

12.

Subcellular targeting of Salmonella virulence proteins by host-mediated S-palmitoylation.

Hicks, Stuart W; Charron, Guillaume; Hang, Howard C; Galán, Jorge E.

Cell Host Microbe ; 10(1): 9-20, 2011 Jul 21.

Article in English | MEDLINE | ID: mdl-21767808

13.

Hijacking the host ubiquitin pathway: structural strategies of bacterial E3 ubiquitin ligases.

Hicks, Stuart W; Galán, Jorge E.

Curr Opin Microbiol ; 13(1): 41-6, 2010 Feb.

Article in English | MEDLINE | ID: mdl-20036613

14.

Golgin-160 promotes cell surface expression of the beta-1 adrenergic receptor.

Hicks, Stuart W; Horn, Troy A; McCaffery, J Michael; Zuckerman, David M; Machamer, Carolyn E.

Traffic ; 7(12): 1666-77, 2006 Dec.

Article in English | MEDLINE | ID: mdl-17118120

15.

GCP60 preferentially interacts with a caspase-generated golgin-160 fragment.

Sbodio, Juan I; Hicks, Stuart W; Simon, Dan; Machamer, Carolyn E.

J Biol Chem ; 281(38): 27924-31, 2006 Sep 22.

Article in English | MEDLINE | ID: mdl-16870622

16.

Isoform-specific interaction of golgin-160 with the Golgi-associated protein PIST.

Hicks, Stuart W; Machamer, Carolyn E.

J Biol Chem ; 280(32): 28944-51, 2005 Aug 12.

Article in English | MEDLINE | ID: mdl-15951434

17.

The NH2-terminal domain of Golgin-160 contains both Golgi and nuclear targeting information.

Hicks, Stuart W; Machamer, Carolyn E.

J Biol Chem ; 277(39): 35833-9, 2002 Sep 27.

Article in English | MEDLINE | ID: mdl-12130652

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export:

The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.

Differential regulation of two palmitoylation sites in the cytoplasmic tail of the beta1-adrenergic receptor.

A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases.

Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.

Death from within: apoptosis and the secretory pathway.

Golgin-160 is required for the Golgi membrane sorting of the insulin-responsive glucose transporter GLUT4 in adipocytes.

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.

Golgi structure in stress sensing and apoptosis.

Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.

Non-viral adeno-associated virus-based platform for stable expression of antibody combination therapeutics.

Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Subcellular targeting of Salmonella virulence proteins by host-mediated S-palmitoylation.

Hijacking the host ubiquitin pathway: structural strategies of bacterial E3 ubiquitin ligases.

Golgin-160 promotes cell surface expression of the beta-1 adrenergic receptor.

GCP60 preferentially interacts with a caspase-generated golgin-160 fragment.

Isoform-specific interaction of golgin-160 with the Golgi-associated protein PIST.

The NH2-terminal domain of Golgin-160 contains both Golgi and nuclear targeting information.